
               
               
               7 DRUG INTERACTIONS
               
                  The concomitant use of PRADAXA with P-gp inducers (e.g., rifampin) reduces exposure to dabigatran and should generally be avoided 
                        [see Clinical Pharmacology (12.3)]
                     . 
                  P-gp inhibitors ketoconazole, verapamil, amiodarone, quinidine, and clarithromycin do not require dose adjustments. These results should not be extrapolated to other P-gp inhibitors 
                        [see Clinical Pharmacology (12.3)]
                     .
               
               
            
         